SCM
BIIB icon

Symons Capital Management’s Biogen BIIB Stock Holding History

Symons Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$4.95M Sell
17,481
-1,229
-7% -$403K 3.17% 10
2021
Q2 		$6.48M Sell
18,710
-830
-4% -$251K 3.69% 8
2021
Q1 		$5.47M Buy
+19,540
New +$5.27M 2.86% 12

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Symons Capital Management's BIIB Position: Q3 2021 in Review

Symons Capital Management reduced its Biogen (BIIB) stake by 6.6% in Q3 2021, selling an estimated $403K and leaving 17,481 shares worth $4.95M. The position accounts for 3.17% of the portfolio, ranked #10.

Symons Capital Management first reported a position in BIIB in Q1 2021 and has held it in 3 quarters since. The position peaked at $6.48M in Q2 2021. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Symons Capital Management held 17,481 shares of Biogen worth $4.95M as of Q3 2021.
  • Symons Capital Management sold 1,229 Biogen shares in Q3 2021, an estimated $403K.
  • Biogen made up 3.17% of Symons Capital Management's portfolio in Q3 2021, its #10 holding.
  • Symons Capital Management first reported a position in Biogen in Q1 2021 and has held it in 3 quarters since.
  • Symons Capital Management's Biogen position peaked at $6.48M in Q2 2021.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Symons Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.